—MAR
— • —
$354.10
P/E
37.29
PEG
0.03
FCF Yield
—
Rev Growth YoY
+433.0% YoY
Gross Margin
1994.0%
Health Score
3/10
D/E Ratio
17.72
Confidence
LOW
Business Snapshot
The ticker and exchange identifiers are absent from this payload, making it impossible to name the company directly. Based on available data, this appears to be a micro- or small-cap entity given the structural characteristics of the financial data, though the market capitalisation figure is not provided for precise tier classification. The company operates in an unspecified sector and industry, which limits contextual benchmarking.
Financial Health
**Score: 3/10** The financial health picture is deeply conflicted. On the surface, reported gross margins of 1,994% and net margins of 993% appear extraordinary — but figures of this magnitude almost certainly reflect accounting anomalies, non-recurring items, or data quality issues rather than genuine operational efficiency, and should be treated with extreme scepticism...
Risk Assessment
- **DEBT:** Debt/equity of 17.72x is extremely elevated and suggests the company is heavily dependent on borrowed capital, creating significant financial fragility. - **LIQUIDITY:** Current ratio of 0.43x means current liabilities are more than twice current assets, raising near-term solvency concerns. - **DATA INTEGRITY:** Gross margins of 1,994% and net margins of 993% are economically implausible under normal operating conditions and may indicate data errors, restatements, or one-time accounting events. - **CASH FLOW OPACITY:** Free cash flow is unavailable, making it impossible to verify whether reported profits translate into real cash generation or debt-servicing capacity. - **TECHNICAL DETERIORATION:** A confirmed death cross (50-day MA crossing below 200-day MA) combined with a bearish MACD signal indicates worsening price momentum. ---...